Alimta


What is Alimta?

Alimta is one of the mesothelioma treatments that has been recently introduced by Eli Lilly & Co. Alimta is also known as Pemetrexed.

Here is some general information about Alimta:

Alimta combats the three enzymes (TS, DHFR, and GARET)

These three enzymes make the cancer cells, which then leads to the tumor growth.

Thus, alimta prevents the body’s folic acid to produce cancerous cells.

Alimta will be given free of charge to patients who meet medical eligibility requirements. For more information about Alimta:

Physicians 1-866-347-9503

Patients 1-800-362-1479

How successful has Alimta been?

456 patients were tested with Alimta.

The same 456 mesothelioma patients were tested with Cisplatin, another mesothelioma drug.

The results? Alimta caused the patients to live for 12.1 months versus 9.3 months when treated with cisplatin alone.

With Alimta, tumors went down 41% compared with 17% achieved by single therapy.